schestowitz@joindiaspora.com
Dr. Roy Schestowitz

#Novartis and #EPO join forces to kill more women with breast #cancer in the name of profit http://patentblog.kluweriplaw.com/2021/11/15/everolimus-breast-cancer-use-patent-considered-valid-in-preliminary-injunction-proceedings-in-italy-and-then-upheld-at-first-instance-in-the-epo/ see http://techrights.org/2015/12/26/epo-and-cancer/

Everolimus breast cancer use patent considered valid in preliminary injunction proceedings in Italy and then upheld at first instance in the EPO - Kluwer Patent Blog

On 9 July 2021, the Court of Milan issued a preliminary injunction (PI) prohibiting a generic company from selling everolimus for use in combination with an aromatase inhibitor in the treatment of hormone receptor positive breast tumours.  The PI...

There are no comments yet.